NCT06352190View on ClinicalTrials.gov

A Study to Evaluate the Mass Balance of [14C] SY-5007 in Healthy Adult Male Subjects in China

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

June 1, 2024

Study Completion Date

June 1, 2024

Conditions

Healthy Subjects

Interventions

DRUG

[14C] SY-5007

Carbon-14 labeled SY-5007

Trial Locations (1)

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

All Listed Sponsors

lead

Shouyao Holdings (Beijing) Co. LTD

OTHER